Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Tax Provisions (2016 - 2023)

Wave Life Sciences' Tax Provisions history spans 8 years, with the latest figure at -$700000.0 for Q3 2023.

  • For Q3 2023, Tax Provisions changed N/A year-over-year to -$700000.0; the TTM value through Jun 2024 reached -$700000.0, down 202.79%, while the annual FY2023 figure was -$677000.0, 199.41% down from the prior year.
  • Tax Provisions reached -$700000.0 in Q3 2023 per WVE's latest filing, down from $681000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $681000.0 in Q4 2022 to a low of -$841000.0 in Q4 2020.
  • Average Tax Provisions over 4 years is -$266000.0, with a median of -$452000.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: soared 75.74% in 2021, then skyrocketed 433.82% in 2022.
  • A 4-year view of Tax Provisions shows it stood at -$841000.0 in 2020, then skyrocketed by 75.74% to -$204000.0 in 2021, then surged by 433.82% to $681000.0 in 2022, then crashed by 202.79% to -$700000.0 in 2023.
  • Per Business Quant, the three most recent readings for WVE's Tax Provisions are -$700000.0 (Q3 2023), $681000.0 (Q4 2022), and -$204000.0 (Q4 2021).